These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 923610)

  • 21. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma hormones in pre- and postmenopausal breast cancer.
    Drafta D; Schindler AE; Milcu SM; Keller E; Stroe E; Horodniceanu E; Bălănescu I
    J Steroid Biochem; 1980 Jul; 13(7):793-802. PubMed ID: 6774172
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.
    Skinner LG; England PC; Cottrell KM; Selwood RA
    Br J Cancer; 1974 Aug; 30(2):176-7. PubMed ID: 4419442
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle.
    Cole EN; Sellwood RA; England PC; Griffiths K
    Eur J Cancer (1965); 1977 Jun; 13(6):597-603. PubMed ID: 880967
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correlations between PRL and 17-beta-E in human breast cancer].
    Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
    Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a low-fat diet on hormone levels in healthy pre- and postmenopausal women: relevance for breast cancer.
    Crighton IL; Dowsett M; Hunter M; Shaw C; Smith IE
    Eur J Cancer; 1992; 28A(12):2024-7. PubMed ID: 1419300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].
    Grodecka-Gazdecka S; Baron J
    Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prolactin and estradiol levels during hormone therapy of breast cancer].
    Grodecka-Gazdecka S; Chwalisz K; Baron J
    Ginekol Pol; 1985 Apr; 56(4):195-201. PubMed ID: 4043797
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolactin levels in populations at risk for breast cancer.
    Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
    Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prolactin and steroid hormones in the blood in local disorders of the lymph-plasma circulation in breast cancer patients].
    Berzin SA; Tokar' VN
    Sov Med; 1988; (12):16-9. PubMed ID: 3242113
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer.
    Bulbrook RD; Moore JW; Clark GM; Wang DY; Tong D; Hayward JL
    Eur J Cancer (1965); 1978 Dec; 14(12):1369-75. PubMed ID: 738341
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Am J Med; 1979 Feb; 66(2):229-37. PubMed ID: 425966
    [No Abstract]   [Full Text] [Related]  

  • 36. Dehydroepiandrosterone sulfate, estradiol and non-protein-bound estradiol serum concentrations in postmenopausal women with and without breast disease.
    Dalski J; Schumann W; Görlich M
    Tumori; 1998; 84(6):720-1. PubMed ID: 10080685
    [No Abstract]   [Full Text] [Related]  

  • 37. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
    Kwa HG; Wang DY
    Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
    Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.